Patents by Inventor Beate Schmidt

Beate Schmidt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Piperazino-derivatives and their use as pde4 inhibitor
    Publication number: 20040132721
    Abstract: The compounds of formula I, in which R1, R2, R3, A, X, s and R9 have the meanings as given in the description are novel effecfive PDE4 inhibitors.
    Type: Application
    Filed: October 23, 2003
    Publication date: July 8, 2004
    Inventors: Gerhard Grundler, Beate Schmidt, Geert Jan Sterk
  • Phthalatyinone-piperidino-derivatives as pde4 inhibitors
    Publication number: 20040067946
    Abstract: The compounds of a formula I, in which the given substituents have the meanings as given in the description, are novel effective PDE4 inhibitors.
    Type: Application
    Filed: August 13, 2003
    Publication date: April 8, 2004
    Inventors: Gerhard Grundler, Beate Schmidt, Geert Jan Sterk
  • (Dihydro) Isoquinoline derivatives as phosphodiesterase inhibitors
    Publication number: 20040044212
    Abstract: 3,4-Dihydroisoquinoline and isoquinoline compounds of formula I, in which Ar represents a phenyl raidcal of the formulae IIa, IIb or IIc are novel effective PDE7 inhibitors.
    Type: Application
    Filed: August 21, 2003
    Publication date: March 4, 2004
    Inventors: Steffen Weinbrenner, Beate Schmidt, Gerlard Grundler, Josef Stadwieser, Armin Hatzelmann, Geert Jan Sterk
  • Novel 6-heteroarylphenanthridines
    Publication number: 20040038979
    Abstract: Compounds of the formula I, in which Het is an unsubstituted or R6-and/or R7-sustituted pyrrolyl, furanyl, thiophenyl, pyrazolyl, imidazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, thiadiazolyl, pyrimidinyl, pyrazinyl or pyridazinyl radical, or an unsubstituted or R6-and/or R7-substituted fused bi-or tricyclic ring system comprising at least one aromatic ring and up to 4 heteroatoms—selected from the group consisting of O(oxygen), S(sulphur) or N(nitrogen)—which is bonded to the phenanthridinyl radical via one of the rings comprising one or more rheteroatoms, areactive PDE4 inhibitors.
    Type: Application
    Filed: December 9, 2002
    Publication date: February 26, 2004
    Inventor: Beate Schmidt
  • Phenanthridine-N-oxides
    Patent number: 6630483
    Abstract: N-oxides of the compounds of formula (I) in which R1 is hydroxyl, 1-4C-alkoxy, 3-7C-cycloalkoxy, 3-7C-cycloalkylmethoxy or completely or predominantly fluorine-substituted 1-4C-alkoxy, R2 is hydroxyl, 1-4C-alkoxy, 3-7C-cycloalkoxy, 3-7C-cycloalkylmethoxy or completely or predominantly fluorine-substituted 1-4C-alkoxy, or in which R1 and R2 together are a 1-2C-alkylenedioxy group, R6 is an R7- and R8-substituted phenyl radical, they are active bronchial therapeutics.
    Type: Grant
    Filed: June 18, 2002
    Date of Patent: October 7, 2003
    Assignee: Altana Pharma AG
    Inventor: Beate Schmidt
  • Phenanthridine-n-oxides
    Publication number: 20030105123
    Abstract: N-oxides of the compounds of formula (I) in which R1 is hydroxyl, 1-4C-alkoxy, 3-7C-cycloalkoxy, 3-7C-cycloalkylmethoxy or completely or predominantly fluorine-substituted 1-4C-alkoxy, R2 is hydroxyl, 1-4C-alkoxy, 3-7C-cycloalkoxy, 3-7C-cycloalkylmethoxy or completely or predominantly fluorine-substituted 1-4C-alkoxy, or in which R1 and R2 together are a 1-2C-alkylenedioxy group, R6 is an R7- and R8-substituted phenyl radical, they are active bronchial therapeutics.
    Type: Application
    Filed: June 18, 2002
    Publication date: June 5, 2003
    Inventor: Beate Schmidt